Loading...
•
Sep 30, 2021
SelectQuote Q1 2022 Earnings Report
SelectQuote reported Q1 2022 results with revenue up 29% year-over-year.
Key Takeaways
SelectQuote's Q1 2022 revenue increased by 29% year-over-year to $159.9 million. The company reported a net loss of $45.4 million and an adjusted EBITDA of $(44.0) million. The full-year guidance remains unchanged.
Consolidated revenue increased by 29% year-over-year to $159.9 million.
Net loss for the quarter was $45.4 million, a decrease of $46.2 million compared to the previous year.
Adjusted EBITDA was $(44.0) million, compared to $12.1 million in the prior year.
SelectRx enrollments are now over 7 times higher than at the time of acquisition.
Revenue by Segment
Forward Guidance
SelectQuote began 2022 with strong results that were ahead of internal expectations, and our full year guidance remains unchanged.
Positive Outlook
- Strong results that were ahead of internal expectations.
- Full year guidance remains unchanged.
- Early progress of Population Health business.
- SelectRx continues to excel, with daily enrollments now over 7 times higher than the rate of enrollment at the time of our acquisition.
- SelectQuote is very well positioned for another year of strong revenue and EBITDA growth
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...